Remote transcranial stimulation for chronic fatigue syndrome
Application of Direct Current Transcranial stImulation, Remotely superVised in Chronic fATiguE - Heimanwendung Der Transkraniellen Gleichstromstimulation Zur Behandlung Der Chronischen Fatigue
This study is testing whether a home device that uses mild electrical stimulation can help people with chronic fatigue syndrome feel better and improve their overall health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Regensburg Academic / other |
| Locations | 1 site (Regensburg) |
| Trial ID | NCT05791812 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility and effectiveness of home-based transcranial direct current stimulation (tDCS) for patients with myalgic encephalomyelitis/chronic fatigue syndrome. It is an open-label interventional study involving 20 participants who will use the tDCS device remotely. The study aims to assess usability, patient compliance, and clinical outcomes related to fatigue and overall health. Participants will be monitored for their experience with the device and the teletherapy approach.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with myalgic encephalomyelitis/chronic fatigue syndrome who reside near Regensburg and speak German.
Not a fit: Patients with contraindications for transcranial direct current stimulation or certain neurological conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could provide a new, accessible treatment option for patients suffering from chronic fatigue syndrome.
How similar studies have performed: While the approach of using tDCS for chronic fatigue syndrome is relatively novel, similar studies in other conditions have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ME/CFS diagnosis according to the Canadian Consensus Criteria * residence near Regensburg and mother language German * written informed consent * stable medication if possible Exclusion Criteria: * contraindications for transcranial direct current stimulation * certain neurological conditions as assessed by study physician * participation in another study * pregnancy and lactation period
Where this trial is running
Regensburg
- Department of Psychiatry and Psychotherapy, University of Regensburg — Regensburg, Germany (Recruiting)
Study contacts
- Principal investigator: Berthold Langguth — University of Regensburg
- Study coordinator: Tobias Hebel
- Email: tobias.hebel@medbo.de
- Phone: +49-941-1250
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.